Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2018-07, Vol.93 (7), p.E162-E164
Hauptverfasser:	Pungolino, Ester, Rossi, Giuseppe, De Canal, Gabriella, Trojani, Alessandra, D'adda, Mariella, Perego, Alessandra, Orlandi, Ester Maria, Lunghi, Francesca, Turrini, Mauro, Borin, Lorenza, Iurlo, Alessandra, Latargia, Maria Luisa, Carraro, Maria Cristina, Spina, Francesco, Lodola, Milena, Artale, Salvatore, Anghilieri, Michela, Spedini, Pierangelo, Cantoni, Silvia, Di Camillo, Barbara, Morra, Enrica, Cairoli, Roberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Antigens, CD34 - analysis Bone marrow Bone Marrow Cells - drug effects Bone Marrow Cells - pathology CD34 antigen Cell Count Chronic myeloid leukemia Female Hematology Humans Inhibitor drugs Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology Male Middle Aged Myeloid leukemia Neoplastic Stem Cells - pathology Prospective Studies Protein Kinase Inhibitors - therapeutic use Pyrimidines - pharmacology Targeted cancer therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!